Risk of Perihippocampal Recurrence After Hippocampal Avoidance in Prophylactic Cranial Irradiation: A Literature Review
- PMID: 40662009
- PMCID: PMC12258414
- DOI: 10.7759/cureus.86007
Risk of Perihippocampal Recurrence After Hippocampal Avoidance in Prophylactic Cranial Irradiation: A Literature Review
Abstract
A standard practice in the treatment of patients with small-cell lung cancer (SCLC) is prophylactic cranial irradiation (PCI) to reduce the chance of brain metastases. However, whole brain radiation therapy (WBRT) has been associated with concerns about neurocognitive decline. This has led to the development of WBRT techniques with the simultaneous avoidance of the hippocampus (HA). This article reviews the existing literature on the incidence of hippocampal failure after HA PCI in patients with SCLC. The effort to protect the hippocampus aims to reduce side effects at a cognitive level, but, as reported in various studies, the results regarding safety and effectiveness are ambiguous. Some indicate a higher risk of recurrence in the hippocampal and perihippocampal regions, particularly in non-oligometastatic patients. Despite any concerns, many trials have shown that HA in PCI significantly reduces cognitive decline without compromising overall survival or control of brain metastases. The mixed results noted between studies indicate the necessity of clinical trials to elucidate the benefits and risks of PCI with simultaneous hippocampal protection in patients suffering from SCLC.
Keywords: failure; hippocampal avoidance; pci; prophylactic cranial irradiation; radiotherapy; small-cell lung cancer.
Copyright © 2025, Giakoumettis et al.
Conflict of interest statement
Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.
Figures
References
-
- Cancer statistics, 2024. Siegel RL, Giaquinto AN, Jemal A. CA Cancer J Clin. 2024;74:12–49. - PubMed
-
- Brain metastases from small cell lung cancer: chemotherapy, radiotherapy, or both? Postmus PE. Semin Radiat Oncol. 1995;5:69–73. - PubMed
-
- CNS metastases in small cell bronchogenic carcinoma: increasing frequency and changing pattern with lengthening survival. Nugent JL, Bunn PA Jr, Matthews MJ, Ihde DC, Cohen MH, Gazdar A, Minna JD. Cancer. 1979;44:1885–1893. - PubMed
-
- Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group. Aupérin A, Arriagada R, Pignon JP, et al. N Engl J Med. 1999;341:476–484. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous